• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4632503)   Today's Articles (6889)   Subscriber (49898)
For: Fisher M. Dapagliflozin and DAPA‐HF: from glycaemic control to heart failure therapy. Pract Diab 2019. [DOI: 10.1002/pdi.2243] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Number Cited by Other Article(s)
1
Liu L, Luo H, Liang Y, Tang J, Shu Y. Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-κB. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE 2022;2022:3293054. [PMID: 35096128 PMCID: PMC8794691 DOI: 10.1155/2022/3293054] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/12/2021] [Revised: 12/15/2021] [Accepted: 12/18/2021] [Indexed: 12/11/2022]
2
Begg A. Dapagliflozin for heart failure. PRACTICAL DIABETES 2021. [DOI: 10.1002/pdi.2324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA